Gilead Sciences, Inc. (GILD)

Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	29,087	28,754	27,116	27,281	27,305	24,689
Revenue Growth (YoY)	2.79%	6.04%	-0.60%	-0.09%	10.60%	9.98%
Cost of Revenue	6,190	6,251	6,019	5,657	5,526	3,691
Gross Profit	22,897	22,503	21,097	21,624	21,779	20,998
Selling, General & Admin	5,880	6,000	6,062	5,673	5,246	5,112
Research & Development	5,818	5,816	5,758	4,977	4,601	4,927
Operating Expenses	11,698	11,816	11,820	10,650	9,847	10,039
Operating Income	11,199	10,687	9,277	10,974	11,932	10,959
Interest Expense	-1,018	-977	-944	-935	-1,001	-984
Interest & Investment Income	281	281	376	106	-	-
Currency Exchange Gain (Loss)	14	14	-12	-	-23	-
Other Non Operating Income (Expenses)	48	-15	2	-30	-6	244
EBT Excluding Unusual Items	10,524	9,990	8,699	10,115	10,902	10,219
Merger & Restructuring Charges	-178	-189	-527	-	-	-920
Gain (Loss) on Sale of Investments	72	-274	-167	-657	-610	-1,662
Legal Settlements	-	-	-	-	-1,075	-
Other Unusual Items	132	7	60	-	-	-
Pretax Income	9,886	691	6,860	5,814	8,278	1,669
Income Tax Expense	1,776	211	1,247	1,248	2,077	1,580
Earnings From Continuing Operations	8,110	480	5,613	4,566	6,201	89
Minority Interest in Earnings	-	-	52	26	24	34
Net Income	8,110	480	5,665	4,592	6,225	123
Net Income to Common	8,110	480	5,665	4,592	6,225	123
Net Income Growth	6336.51%	-91.53%	23.37%	-26.23%	4960.98%	-97.72%
Shares Outstanding (Basic)	1,246	1,247	1,248	1,255	1,256	1,257
Shares Outstanding (Diluted)	1,262	1,255	1,258	1,262	1,262	1,263
Shares Change (YoY)	1.02%	-0.24%	-0.32%	-	-0.08%	-1.10%
EPS (Basic)	6.51	0.38	4.54	3.66	4.96	0.10
EPS (Diluted)	6.42	0.38	4.50	3.64	4.93	0.10
EPS Growth	6514.05%	-91.56%	23.63%	-26.17%	4938.22%	-97.68%
Free Cash Flow	9,162	10,305	7,421	8,344	10,805	7,518
Free Cash Flow Per Share	7.26	8.21	5.90	6.61	8.56	5.95
Dividend Per Share	3.140	3.080	3.000	2.920	2.840	2.720
Dividend Growth	2.61%	2.67%	2.74%	2.82%	4.41%	7.94%
Gross Margin	78.72%	78.26%	77.80%	79.26%	79.76%	85.05%
Operating Margin	38.50%	37.17%	34.21%	40.23%	43.70%	44.39%
Profit Margin	27.88%	1.67%	20.89%	16.83%	22.80%	0.50%
Free Cash Flow Margin	31.50%	35.84%	27.37%	30.59%	39.57%	30.45%
EBITDA	13,965	13,454	11,970	13,077	13,982	12,439
EBITDA Margin	48.01%	46.79%	44.14%	47.93%	51.21%	50.38%
D&A For EBITDA	2,766	2,767	2,693	2,103	2,050	1,480
EBIT	11,199	10,687	9,277	10,974	11,932	10,959
EBIT Margin	38.50%	37.17%	34.21%	40.23%	43.70%	44.39%
Effective Tax Rate	17.96%	30.54%	18.18%	21.46%	25.09%	94.67%
Revenue as Reported	29,087	28,754	27,116	27,281	27,305	24,689
Advertising Expenses	-	869	826	778	735	795

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q